Cargando…
Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
PURPOSE: Nonsurgical therapies, including biotherapy, chemotherapy, and liver-directed therapy, provided a limit survival benefit for PNET patients with hepatic metastases. With the development of liver resection technique, there was a controversy on whether to perform a liver resection for these pa...
Autores principales: | Yu, Xinzhe, Gu, Jichun, Wu, Haoxuan, Fu, Deliang, Li, Ji, Jin, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261248/ https://www.ncbi.nlm.nih.gov/pubmed/30538745 http://dx.doi.org/10.1155/2018/6273947 |
Ejemplares similares
-
Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases
por: Yu, Xinzhe, et al.
Publicado: (2017) -
Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases
por: Tao, Lianyuan, et al.
Publicado: (2017) -
Resection and thermal hepatic ablation of pancreatic neuroendocrine tumor liver metastases for prolonged survival
por: Ke, Xindi, et al.
Publicado: (2022) -
The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases
por: Mou, Yu, et al.
Publicado: (2022) -
Is Long-Term Survival in Metastases from Neuroendocrine Neoplasms Improved by Liver Resection?
por: Kraft, Alin, et al.
Publicado: (2021)